{"id":422945,"title":"Order Amending Schedule V to the Controlled Drugs and Substances Act (Fentanyl Precursors and Carisoprodol) - Canada.ca","sourceCode":"hc","sourceName":"Health Canada","language":"en","captureDate":"2026-01-17","captureTimestamp":"2026-01-17T01:13:04.573000+00:00","jobId":6,"originalUrl":"https://www.canada.ca/en/health-canada/services/health-concerns/controlled-substances-precursor-chemicals/order-amending-schedule-v-controlled-drugs-substances-act-fentanyl-precursors-carisoprodol.html","snippet":"Order Amending Schedule V to the Controlled Drugs and Substances Act (Fentanyl Precursors and Carisoprodol) Whereas, in accordance with paragraph 60.1(1)(a) Footnote a of the Controlled Drugs and Substances Act Footnote b , the Minister of Mental Health and Addictions and…","rawSnapshotUrl":"/api/snapshots/raw/422945","browseUrl":"https://replay.healtharchive.ca/job-6/20260117011304/https://www.canada.ca/en/health-canada/services/health-concerns/controlled-substances-precursor-chemicals/order-amending-schedule-v-controlled-drugs-substances-act-fentanyl-precursors-carisoprodol.html#ha_snapshot=422945","mimeType":"text/html","statusCode":200,"captureBackend":"browsertrix","captureFidelity":"high"}